A group of leupeptin analogues was found in Streptomyces griseus strain 254, isolated from a soil sample from Fujian Province, China. The inhibitors excreted in the culture filtrate were purified by adsorption on macroporous resin, followed by sequential ion exchange chromatography on DEAE-52 cellulose, CM-32 cellulose and affinity chromatography with immobilized trypsin. The preparation thus obtained was further purified by preparative HPLC.Several major components were found and characterized, which possessed different inhibitory properties toward trypsin. Based upon amino acid and mass spectrophotometric analysis, these peptides were placed in four major structural categories, v/z., R-Val-Val-argininal, R-Leu-Leu-argininal, R-Ile-Ile-argininal and R-Thr-Thr-argininal, this latter component representing a newly identified leupeptin analogue. The structural variability of the R-group was partly responsible for the multiplicity of the peaks obtained with HPLC. All peptides displayed varying degrees of inhibitory activity toward proteases involved in blood coagulation and fibrinolysis, including plasmin, factor Xa, activated protein C and thrombin. Amongthese peptide inhibitors, the molecule containing threonine showed the strongest inhibitory activity.
R-Thr-Thr-argininal, this latter component representing a newly identified leupeptin analogue. The structural variability of the R-group was partly responsible for the multiplicity of the peaks obtained with HPLC. All peptides displayed varying degrees of inhibitory activity toward proteases involved in blood coagulation and fibrinolysis, including plasmin, factor Xa, activated protein C and thrombin. Amongthese peptide inhibitors, the molecule containing threonine showed the strongest inhibitory propionyl-leupeptin has been found to inhibit enzymes, belonging to the general classes of serine proteases, thiol proteases and metallo-proteases1'4*, thus providing this inhibitor with a wide variety of effects on cellular function and in vivo properties5~7).
Wehave found that a variety of leupeptin-like molecules exist in Streptomyces griseus and desired to partially characterize their structural features and ability to inhibit a variety of proteases involved in blood coagulation and fibrinolysis.
We desired to develop an HPLCmethod for identification and mild purification of these peptides, since the normal separation of leupeptins containing different R groups relied on reflux and extraction conditions wherein racemization of the L-argininal occurred, providing a mixture in which only a portion of the molecules possessed inhibitory properties8'9*. This report represents a summaryof our efforts in this regard.
Materials and Methods Materials S. griseus strain 254 was isolated from a soil sample collected from Fujian Province, China. Trypsin, thrombin and leupeptin were purchased from the Sigma Chemical Company. Bovine activated protein C10), bovine factor Xaxl) and human plasmin12) were prepared as described. The chromogenic substrates,
were purchased from Helena Laboratories.
Fermentation and Extraction of Leupeptin Analogues S. griseus was grown in a medium containing starch 1 % (w/v), peptone 1.5% (w/v), glycerol 1 %, yeast paste 0.3% (w/v) and NaCl 0.1% (w/v), pH6.8-7.0, for 4 days at 28°C. The cultured broth (4 liters) was centrifuged and the pH of the supernatant was adjusted to 3.0 by addition of 2n HC1. The formed precipitate was removedby centrifugation and the pHof the supernatant was readjusted to pH7.5. This The volume of each fraction was 5ml. All active material was found in the last small peak. (A) A total of 0.2 and 0.3 NIH units of thrombin was employed in a 1-ml reaction mixture containing 1.5 mg of fibrinogen in 0.05 m Hepes-NaOH, pH 7.4. The linear portion of the curves was extrapolated to the abscissa for the measurement of the turbidity increment of fibrin.
(B) The turbidity increments of fibrin were determined as a function of the thrombin concentrations. OCT. 1989 material was applied to an unionized-16 macroporous resin column (3.2 x 40 cm), equilibrated with H2O.
The column was eluted with H2Ountil the eluate was colorless, and then with 50%methanol-H2O, pH 5.0. The active fractions (assayed against trypsin) were pooled and concentrated to dryness, under vacuum at 40°C. The brownish powder was dissolved in a small volume of H2Oand applied to a DEAE-52 cellulose column (3 x 28cm), equilibrated with 0.02m NH4HCO3.The column was washed with the equilibration solution. The active fractions were pooled and reconcentrated to a small volume, at 40°C, under vacuum, and subjected to chromatography on a CM-32cellulose column (2.2 x 38 cm), equilibrated with 0.02m ammonium formate, pH4.0. The column was washed with this same solution until the eluate was colorless. Materials were then eluted with a linear gradient from 0.02 to 0.2m ammoniumformate, pH4.0. The results are shown in Fig. 1 . The active fractions were present in the last small peak. This pool was dried under vacuumand employed as the crude material for further purification.
Enzyme Assays The chromogenic substrate, S2238, was used to assay trypsin and activated protein C, S2251 was employed for assay of plasmin, and S2222 for factor Xa. Assays were conducted at 37°C using a Cary 219 recording spectrophotometer. The stock buffer was 0.5 m Tris-HCl, pH 7.4. In a typical assay, a total of 0.1 ml of buffer and 0.02ml of enzyme were placed in the cuvette. Increasing amounts of the leupeptin analogue were next added, followed by H2O, and 0.02 ml of a fixed concentration of the desired substrate. The final assay volume was 1.0 ml. The rate ofenzymic hydrolysis of the substrate was continually recorded (405 nm) and decreased with increasing concentrations of inhibitor. The experiment was then repeated at a second substrate concentration.
Thrombin activity was determined by the turbidity increment monitored at 350 nm accompanying the polymerization of fibrin monomer/ After a latent time required for the thrombin-catalyzed release of fibrinopeptides A and B from fibrinogen, polymerization of fibrin occurred with an increase in turbidity, which was parallel to the thrombin concentration ( Fluorescence detection was accomplished with a Varian Fluorochrome flow-through filter fluorometer.
The excitation and emission filters covered the ranges of 305~395 nm and 420~650nm, respectively.
An Ultrasphere ODS, 3^m, column (4.6 x 100mm, i.d.) was used for the separations. We have achieved optimal success with the following separation gradient, consisting of two solutions, viz., 80% 0.1 m NaOAc-20% methanol -0.4% THF, pH 5.8 (solution A), and 100% methanol (solution B). The column was equilibrated with solution A. After application of the sample, the column was developed at a flow rate of 1.5 ml/minute with the following linear gradients: 90% A-10% B to 80%A-20% B for 10 minutes; 80% A-20% B to 60% A-40% B for 2.5 minutes; 60% A-40% B to 20% A-80% B for 10minutes; and 20% A-80% B to 100% B for 0.5minute. This procedure led to resolution of all amino acids in a standard amino acid sample.
Mass Spectral Analysis Positive and negative fast atom bombardment (FAB)-MS were obtained at approximately 8 kV, under xenon, with a Finnegan-MATModel 8430 mass spectrometer. Prior to analysis, each sample was dissolved in H2O, followed by addition of a drop of glycerol. In all cases the sample was scanned to 1,020amu.
Results
The crude material obtained after chromatography on CM-32cellulose was further purified by affinity chromatography on immobilized trypsin, as illustrated in Fig. 3 . The active fractions eluted with 0.01 n HC1 were pooled and lyophilized.
The resulting powder was then subjected to preparative HPLC Fig. 3 . Affinity chromatography of crude leupeptin on immobilized trypsin.
After application of the sample, the material on the column (2.2 x 60 cm) was subsequently eluted with 0.4m NaCl, H2O and 0.01n HC1. chromatography employing a C18 (lO jan) column (2.1 x 15 cm) and eluted with a gradient of acetonitrile, as shown in Fig. 4 . Of the 12 main peaks, the first 3 were shown to be contaminants, without inhibitor activity. Peaks 4 and 5 were relatively weak inhibitors, and not further characterized. Peaks 6~12 were individually pooled and dried by rotary evaporation at 40°C, under vacuum. Methanol was added and the samples reevaporated in order to removetraces of trifluoroacteic acid and acetonitrile from the samples. Each sample was then dissolved in H2Oand stored for further characterization.
The amino acid contents of peaks 6~12 are listed in Table 1 . Most of the components were composed He, with the exceptions of peaks 7, which contained Thr as the only amino acid identified, and peak 8, which contained Val and Leu, in equimolar amounts. The material represented by peak 7 is especially important, since a leupeptin analog containing threonine has not been identified to date.
All of the above purified materials showed negative ninhydrin reactions, indicating the presence of blocked amino termini. In addition, all materials were positive in the Sakaguchi reaction and in permanganate oxidation analysis, which in combination with their ability to bind to and inhibit trypsin amidolytic activity, almost certainly shows the presence of argininal at the carboxy-terminus.
The molecular weights of the hydrochloride salts of most of the purified components were determined by mass spectral analysis, and are listed in Table 2 . Employing these molecular weights and quantitative amino acid analysis,we found that the amino acids identified in Table 1 were present in a 2: 1 molar stoichiometry. With this knowledge, we were able to calculate the molecular weight of the R group present on the amino terminus, and suggest its identity, based on homology with leupeptin. Clearly, the different peaks resolved in Fig. 3 , and containing the same amino acid content, represent resolution based on R group differences.
From all of the above information, we conclude that components 6, 7, 9~12 resolved by HPLCin Fig. 3 represent the structures R-X-X-argininal. Peaks 10 and 12, which contain leucine, comigrated with commercial leupeptin in TLC experiments (propanol-H2O, 7: 3)13). Peak 8 may be a mixture of two componentsor maycontain a structure of R-X-Y-argininal. This aspect was not investigated further.
Since the leupeptin analogues were purified by affinity chromatography with immobilized trypsin, it would be expected that they would serve as trypsin inhibitors. Wefound that this inhibition was competitive and reversible and have determined the respective Ki values of these inhibitors to trypsin employing Dixon plots, an example of which is provided in Fig. 5 . The results obtained for all proteases examined are listed in Table 3 . All leupeptin analogues examined were strong inhibitors of trypsin, slightly weaker for plasmin and thrombin, and weakest for activated protein C and factor Xa. Amongthe four classes of inhibitors, the threonine analogue was the most potent inhibitor against all proteases tested. The inhibitory properties toward trypsin of the Pr-leucine leupeptin analogue were compared with commercial leupeptin (Ac-leupeptin) and the results are illustrated in Fig. 5 . The inhibitory potency of the former was approximately 6-fold greater than that of the latter. It is possible that the different acyl groups present contribute to the dissimilarity of their kinetic constants and/or that racemization of the argininal in the commercial preparation occurred during its extraction1 ), yielding an amount of Ac-L-Leu-L-Leu-D-argininal, analogues, that containing threonine displayed a stronger inhibitory activity toward most of the proteases tested. This indicates that a hydrophilic amino acid residue in a leupeptin-like inhibitor might be more suitable for inhibition of serine proteases and provides possibilities for the design of more potent inhibitors. Leupeptin possesses a broad specificity and is capable of inhibiting serine and thiol proteases, including Ca2 +-dependent calpains. The inhibitor dissociation constants (Ki) of leupeptin with different serine proteases varies from 7x10~9m with cathepsin B14) to 8x10~5m with factor IXa15). Using a-iV-tosyl-L-arginine methyl ester and a-Af-benzoyl-L-arginine ethyl ester as the substrates for trypsin, the Ki for leupeptin was found to be 3.4x 10"7m and 1.3 x 10~7m, respectively13). Compared with the values from the literature, our Ki values for leupeptin and its analogues to trypsin were comparatively low (Table 3 ). With our mild purification conditions, it is highly unlikely that any racemization of the L-argininal in leupeptin occurred, whereas commercial preparations, prepared by extraction techniques lead to racemization and partial inactivation of leupeptin. This may partly explain OCT. 1989 the differences in results. Of the other proteases examined, plasmin and thrombin were more strongly inhibited that factor Xa and activated protein C. Finally, it has been shown previously that different forms of Ac-leupeptin that arise through hydration and cyclization of the aldehyde group16), can be resolved by HPLCanalysis. Whena commercial sample of Ac-leupeptin was analyzed on our system, we observe the same three peaks that have been described for this molecule16). Undoubtedly, therefore, some of the shoulders and peaks observed in Fig. 4 represent these isomers. This is the reason that weselected for analysis a limited numberof fractions that contained different amino acids. It is likely that under the conditions for mass spectral analysis the isomeric mixture would not be present and a single molecular size would be obtained. In any event, the leupeptins identified would represent a minimal number that likely exist in the crude culture supernate.
In conclusion, we have described a facile method for purifying and resolving different leupeptin analogues of microbial origin. A variety of leupeptin-like inhibitors have been found, differing in amino acid and acyl components. The new analogue, containing threonine, was the most potent inhibitor toward five different serine proteases.
